Japan's Shimadzu Corporation has released CellTune software for supporting optimisation of cell culture conditions that ...
Japan-based pharmaceutical firm Takeda and Boston Medical Center (BMC) in the US have announced a new collaboration focu...
Namsa, a US-based medical device contract research organisation (CRO) providing comprehensive market access services, an...
Honkuwa Pharmaceutical Co. has reached a strategic alliance agreement with Professor Yoshiki Sawa, a member of the Japan...
Japan-based Ono Pharmaceutical Co. has entered into a license agreement with LigaChem Biosciences, Inc., in South Korea,...
Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technolo...
UK-based AviadoBio and Japan's Astellas Pharma Inc. have announced an exclusive option and license agreement for AVB-101...
Flatiron Health and Lifebit Biotech are expanding their collaboration into Japan to transform cancer care, facilitating ...
Japan-based startup Rege Nephro Co. has successfully developed a funding plan of total 25 billion yen (¥) in new Ser...
Paris-based Curium, a world leader in nuclear medicine, has entered into a strategic partnership with PDRadiopharma Inc,...
Japan's TERUMO Asia Holdings has launched its “Terumo Asia Skill Lab” at its Asia-Pa...
Olympus Corporation, a global medtech company headquartered in Japan, has announced the launch of VISERA S, the all-in-o...
US-based Boston Scientific Corporation has received Pharmaceuticals and Medical Device Agency (PMDA) approval in&nb...
Nxera Pharma, formerly known as Sosei Group or Sosei Heptares, has received approval from the Ministry of Health, Labour...
Japanese pharma firm Takeda has awarded JPY 4.6 billion (approximately $32 million) to five new partners in the field of...
Japan's Shimadzu Corporation has established a subsidiary in Mexico and has begun its activities. To date, in Mexico, an...
US-based iRhythm Technologies, Inc., a leading digital healthcare company focused on creating trusted solutions that det...
Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...
